Ken Griffin Inotiv, Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.28 - $2.26 $29,312 - $51,753	-22,900 Reduced 95.42%	1,100 $1,000
Q2 2024 Aug 14, 2024	SELL	$1.66 - $9.87 $41,168 - $244,775	-24,800 Reduced 50.82%	24,000 $39,000
Q1 2024 May 15, 2024	BUY	$3.27 - $11.04 $130,800 - $441,599	40,000 Added 454.55%	48,800 $533,000
Q4 2023 Feb 14, 2024	SELL	$1.69 - $3.86 $45,461 - $103,834	-26,900 Reduced 75.35%	8,800 $32,000
Q3 2023 Nov 14, 2023	BUY	$3.01 - $7.32 $3,912 - $9,516	1,300 Added 3.78%	35,700 $109,000
Q2 2023 Aug 14, 2023	SELL	$4.08 - $7.22 $33,048 - $58,482	-8,100 Reduced 19.06%	34,400 $164,000
Q1 2023 May 15, 2023	BUY	$4.18 - $8.64 $20,482 - $42,336	4,900 Added 13.03%	42,500 $184,000
Q4 2022 Feb 14, 2023	SELL	$3.77 - $22.1 $282,750 - $1.66 Million	-75,000 Reduced 66.61%	37,600 $185,000
Q3 2022 Nov 14, 2022	BUY	$9.81 - $26.17 $1.1 Million - $2.95 Million	112,600 New	112,600 $1.9 Million

3.67M

1.1K

21.3K

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $68.6M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.